Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
Closed Solicitation Posted
- Solicitation number
- 24-007309
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH), through the Office of Purchasing and Contracts, is seeking to procure BD Rhapsody Single-Cell Analysis Reagent Kits. The key requirements include providing technical support for the kits and reagents, ensuring safe transport and maintaining appropriate temperature and other parameters during shipment. The contractor will be paid per product delivered, and the government will not compete the proposed requirement based on responses to this notice.
The acquisition is not set-aside, and the applicable NAICS code is 325413 (In Vitro Diagnostic Substance Manufacturing) with a small business size standard of 1,250 average number of employees. The Place of Performance is Bethesda, MD 20892, USA. The estimated quantity of the various kits and reagents is five each, and the period of performance is one-time delivery from 5/1/2024 to 8/30/2024.
Notice text
Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
- Product Service Code: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- NAICS Code: 325413- In Vitro Diagnostic Substance Manufacturing (Small Business Size Standards- 1,250 Average Number of Employees)
- Place of Performance:
Bethesda, MD 20892 USA
POTS: 24-007309
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Office of Purchasing and Contracts (OPC) Notice of Intent
The Center for Cellular Engineering (CCE) is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH.
3.1 This is a standing order with multi-type of sequencing kits and reagents as all those kits and reagents with very short shelf life. In order to keep study going forward and save funding.
3.2 The contractor will ship sufficient reagents and kits following the scheduled delivery dates unless otherwise agreed to early release by requester.
3.3 Shelf life-Minimum: Shelf life of any up opened sequencing reagents shall be at least 3 months unless otherwise agreed to from date of delivery at the CCE, PACT laboratory. Shelf life of library generation kits shall be at least 6 months from date of delivery to CCE.
3.4 The kits and quantity listed below.
Line Items: Description Quantity Catalog
Rhapsody Targeted mRNA AbSeq Kit- 4 Pack*-V2 beads 5 665913
Ab-O Single Cell Sample Multiplexing Kit 5 633781
BD Rhapsody Immune Response Panel Hs 5 633750
BD AbSeq Immune Discovery Panel CTT 5 625970
3.5 The contractor shall supply technical support for all kits and reagents and their performance characteristics at no additional cost to the government.
4. Period of Performance
This is one-time delivery, the period of performance for these products should occur: 5/1/2024-8/30/2024.
5. Delivery Schedule
This is one-time delivery. These reagents and kits will be shipped overnight delivery Monday through Thursday to:
Attention: Lipei Shao
Center for Cellular Engineering(CCE), NIH/CC
10 Center Drive
Bldg. 10/ Rm. 2C328
Bethesda, MD 20892-1288
7. Requirements
The vendor will provide full report documenting the safe transport of cryopreserved patient cells from outside institutions to the NIH.
The Vendor will ensure that temperature and other parameters are maintained during the shipment of reagents and kits. This will ensure the desired outcomes in the center for cellular engineering clinical research protocols.
8. Tasks
This is a contract for shipment of clinical cellular material at appropriate temperatures and other conditions to ensure optimum quality for further cell therapy manufacturing and patient treatment.
9. Schedules/Milestones
The contractor shall be paid per product delivered
10. Transmittal/Delivery/Accessibility
The contractor shall provide [1] hard copies of proofs of each product delivered and a PDF
The contractor shall bear the cost of replacement for reagents and disposables found to be damaged or defective upon receipt by NIH or for incorrect or incomplete shipments.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Damien Goines, Contract Specialist, damien.goines@nih.gov by May 1ST 9:00AM EST.
*** Please send your capability statements ONLY. This IS NOT a request for proposal. ***
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| BD FACSymphony A-5 Flow Cytometer Maintenance Agreement | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity